ichorbio supplies a range of HLA-DQ antibodies including low endotoxin versions for in vivo research and conjugated HLA-DQ antibodies for flow cytometry, western blotting and related applications.
HLA-DQ antibodies: Low Endotoxin
HLA-DQ antibodies: Conjugated
ichorbio supplies a range of conjugated antibodies to HLA-DQ.
HLA-DQ is an isotype of MHC class II together with HLA-DP, HLA-DM, HLA-DO and HLA-DR
HLA-DQ is encoded on chromosome 6 in the region 6p21; the DQ isotype is located specifically at 6p21.31. HLA-DQ is made up of two subunits: alpha (α) and beta (β).
The currently used serotypes are HLA-DQ2, -DQ3, -DQ4, -DQ5, -DQ6, -DQ7, -DQ8, -DQ9.
MHC Class II
MHC Class II proteins are up-regulated in response to signalling as part of the immune response. They form a complex with foreign peptides generally 9 to 30 amino acids in length on the outside of cells which together act as a ligand for the T-cell receptor (TCR) which causes the multiplication of T-helper cells (also called CD4 positive T cells). These cells in turn stimulate antibody-producing B-cells to produce antibodies to the specific foreign peptide that was presented.
Please see image 1 below for a schematic:
DQ is also involved in recognizing common self-antigens and presenting those antigens to the immune system in order to develop tolerance from a very young age. When tolerance to self proteins is lost, DQ may become involved in autoimmune disease.
HLA-DQ in Disease
Two autoimmune diseases in which HLA-DQ is involved are coeliac disease and diabetes mellitus type 1.
DQ is one of several antigens involved in rejection of organ transplants. As a variable cell surface receptor on immune cells, these D antigens, originally HL-A4 antigens, are involved in graft-versus-host disease when lymphoid tissues are transplanted between people.